glp-1 agonists oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Anesthetic Considerations for Patients Taking
Description
While synthetic GLP-1 receptor agonists have revolutionized the management of type 2 diabetes and obesity, a burgeoning interest in natural, plant-derived alternatives is sweeping the wellness landscape
KDOQI clinical practice guideline for nutrition in CKD: 2020 Update
Helmstadter J, Frenis K, Filippou K, et al
However, lean body mass also includes organs, bones, and skin
Int J Surg 110(3):15461555 Coelho C et al (2023) Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial
